{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:08:39Z","timestamp":1761394119329,"version":"3.40.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1124\/jpet.111.186379","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T06:03:58Z","timestamp":1323324238000},"page":"656-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A2\u03b1 for the Treatment of Asthma"],"prefix":"10.1016","volume":"340","author":[{"given":"Christopher A.","family":"Hewson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinnah","family":"Campwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Havard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Luscombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter T.","family":"Peachell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G.","family":"Matera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai L.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas P.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Yeadon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.186379_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.pupt.2008.01.010","article-title":"Modeling of asthma, COPD and cystic fibrosis in sheep","volume":"21","author":"Abraham","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/jpet.111.186379_bib2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF01983121","article-title":"Isolation and properties of cardiac and other mast cells from the rat and guinea-pig","volume":"16","author":"Ali","year":"1985","journal-title":"Agents Actions"},{"key":"10.1124\/jpet.111.186379_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2710.2008.00970.x","article-title":"Inhaled corticosteroids for asthma: are they all the same?","volume":"34","author":"Baptist","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.1124\/jpet.111.186379_bib4","series-title":"Presented at the European Respiratory Society Annual Congress; 2009 Sep 12\u201316; Vienna, Austria","article-title":"A randomised, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 on moderate persistent asthma","author":"Barnes","year":"2009"},{"key":"10.1124\/jpet.111.186379_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/excr.1996.0047","article-title":"Synergistic effect of interleukin-1\u03b2 and tumor necrosis factor \u03b1 on PGE2 production by articular chondrocytes does not involve PLA2 stimulation","volume":"222","author":"Berenbaum","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1124\/jpet.111.186379_bib6","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1164\/ajrccm\/145.5.1087","article-title":"Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine","volume":"145","author":"Bj\u00f6rck","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/jpet.111.186379_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/156652408785160989","article-title":"Eicosanoids in asthma, allergic inflammation, and host defense","volume":"8","author":"Boyce","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1124\/jpet.111.186379_bib8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.111.186379_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1365-2222.2003.01636.x","article-title":"New insights into the role of the mast cell in asthma","volume":"33","author":"Brightling","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1124\/jpet.111.186379_bib10","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1165\/rcmb.2011-0056OC","article-title":"Pharmacological characterization of adenosine receptors on isolated human bronchi","volume":"45","author":"Calzetta","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.111.186379_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1476-5381.2011.01216.x","article-title":"\u03b22-Adrenoceptor agonists: current and future direction","volume":"163","author":"Cazzola","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.186379_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","article-title":"Treatment of asthma with drugs modifying the leukotriene pathway","volume":"340","author":"Drazen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.111.186379_bib13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/thx.41.12.955","article-title":"Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects","volume":"41","author":"Fujimura","year":"1986","journal-title":"Thorax"},{"key":"10.1124\/jpet.111.186379_bib14","first-page":"252","article-title":"Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine","volume":"133","author":"Fuller","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/jpet.111.186379_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.plipres.2006.05.003","article-title":"Properties of the group IV phospholipase A2 family","volume":"45","author":"Ghosh","year":"2006","journal-title":"Prog Lipid Res"},{"year":"2002","series-title":"Global Strategy for Asthma Management and Prevention","key":"10.1124\/jpet.111.186379_bib16"},{"key":"10.1124\/jpet.111.186379_bib17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2036.2010.04442.x","article-title":"Clinical trial: endoscopic evaluation of naproxen etemesil, a naproxen prodrug, vs. naproxen: a proof-of-concept, randomized, double-blind, active-comparator study","volume":"32","author":"Goldstein","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/jpet.111.186379_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.biochi.2010.02.030","article-title":"The role of mast cell-derived secreted phospholipases A2 in respiratory allergy","volume":"92","author":"Granata","year":"2010","journal-title":"Biochimie"},{"key":"10.1124\/jpet.111.186379_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1183\/09031936.95.08030411","article-title":"Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor","volume":"8","author":"Johnston","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.111.186379_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1378\/chest.121.2.334","article-title":"Marginal utility of montelukast for persistent asthma","volume":"121","author":"Mathison","year":"2002","journal-title":"Chest"},{"key":"10.1124\/jpet.111.186379_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/jm0507882","article-title":"Inhibition of cytosolic phospholipase A2\u03b1: hit to lead optimization","volume":"49","author":"McKew","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.111.186379_bib22","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/jm701467e","article-title":"Indole cytosolic phospholipase A2\u03b1 inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib","volume":"51","author":"McKew","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.111.186379_bib23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198609253151304","article-title":"Release of prostaglandin D2 into human airways during acute antigen challenge","volume":"315","author":"Murray","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.111.186379_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/76897","article-title":"Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2","volume":"1","author":"Nagase","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.111.186379_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0952-3278(03)00078-4","article-title":"The second PGD2 receptor CRTH2: structure, properties, and functions in leukocytes","volume":"69","author":"Nagata","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1124\/jpet.111.186379_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbalip.2010.03.003","article-title":"Decrease in expression or activity of cytosolic phospholipase A2\u03b1 increases cyclooxygenase-1 action: a cross-talk between key enzymes in arachidonic acid pathway in prostate cancer cells","volume":"1801","author":"Niknami","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.111.186379_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/thx.46.9.633","article-title":"Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma","volume":"46","author":"Pavord","year":"1991","journal-title":"Thorax"},{"key":"10.1124\/jpet.111.186379_bib28","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1010846","article-title":"Leukotriene antagonists as first-line or add-on asthma-controller therapy","volume":"364","author":"Price","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.111.186379_bib29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000313836","article-title":"CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory disease","volume":"85","author":"Schuligoi","year":"2010","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.111.186379_bib30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","article-title":"Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma","volume":"153","author":"Sestini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.111.186379_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2125.1985.tb02671.x","article-title":"Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1\u03b1 and \u03b2-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment","volume":"19","author":"Shephard","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.111.186379_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0003-2697(74)90093-1","article-title":"An automated continuous-flow system for the extraction and fluorometric analysis of histamine","volume":"57","author":"Siraganian","year":"1974","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.111.186379_bib33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/09031936.93.03050588","article-title":"The cyclooxygenase theory of aspirin-induced asthma","volume":"3","author":"Szczeklik","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.111.186379_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1164\/ajrccm.153.2.8564099","article-title":"Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma","volume":"153","author":"Szczeklik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.111.186379_bib35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/37622","article-title":"Role of cytosolic phospholipase A2 in allergic response and parturition","volume":"390","author":"Uozumi","year":"1997","journal-title":"Nature"},{"key":"10.1124\/jpet.111.186379_bib36","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1398-9995.2010.02414.x","article-title":"Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma","volume":"65","author":"van den Berge","year":"2010","journal-title":"Allergy"},{"key":"10.1124\/jpet.111.186379_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.it.2003.11.001","article-title":"The lung as a privileged site for the beneficial actions of PGE2","volume":"25","author":"Vancheri","year":"2004","journal-title":"Trends Immunol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.186379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:00:03Z","timestamp":1743202803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524467657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0022356524467657"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.186379","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A2\u03b1 for the Treatment of Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.186379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}